Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mesoblast Limited (AU:MSB)
:MSB
MSB Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.29 - AU$3.37
Previous CloseN/A
Volume5.54M
Average Volume (3M)5.02M
Market Cap
AU$3.66B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.63
Next Earnings
Aug 27, 2025EPS Estimate
-0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding1,270,527,200
10 Day Avg. Volume4,029,321
30 Day Avg. Volume5,020,247
Standard Deviation0.32
R-Squared0.17
Alpha0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)24.95
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$3.07Price Target Upside9.89% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Mesoblast Limited News
PremiumCompany Announcements
Change in Substantial Holder Interests at Mesoblast Limited
PremiumCompany Announcements
Mesoblast Launches Ryoncil® in U.S. for Pediatric Graft-Versus-Host Disease
PremiumCompany Announcements
Mesoblast Boosts Capital with New Share Issuance
PremiumCompany Announcements
Mesoblast Limited Quotes New Securities on ASX
---
Options Prices
Currently, No data available
---
Ownership Overview
0.51% Insiders
2.42% Mutual Funds
0.01% Other Institutional Investors
94.68% Public Companies and
Individual Investors
MSB FAQ
What was Mesoblast Limited’s price range in the past 12 months?
Mesoblast Limited lowest share price was AU$0.28 and its highest was AU$3.37 in the past 12 months.
What is Mesoblast Limited’s market cap?
Mesoblast Limited’s market cap is AU$3.66B.
When is Mesoblast Limited’s upcoming earnings report date?
Mesoblast Limited’s upcoming earnings report date is Aug 27, 2025 which is in 186 days.
How were Mesoblast Limited’s earnings last quarter?
Currently, no data Available
Is Mesoblast Limited overvalued?
According to Wall Street analysts Mesoblast Limited’s price is currently Undervalued.
Does Mesoblast Limited pay dividends?
Mesoblast Limited does not currently pay dividends.
What is Mesoblast Limited’s EPS estimate?
Mesoblast Limited’s EPS estimate is -0.04.
How many shares outstanding does Mesoblast Limited have?
Mesoblast Limited has 1,270,527,200 shares outstanding.
What happened to Mesoblast Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Mesoblast Limited?
Currently, no hedge funds are holding shares in AU:MSB
---
Mesoblast Limited Stock Smart Score
Company Description
Mesoblast Limited
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target the cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Itescu Silviu on June 8, 2004 and is headquartered in Melbourne, Australia.
---
MSB Stock 12 Month Forecast
Average Price Target
AU$3.07
▲(9.89% Upside)
Technical Analysis
Biotron Limited
―
Cochlear Limited
―
Cynata Therapeutics Limited
―
Nanosonics Limited
―
Immutep Ltd
―
Best Analysts Covering MSB
1 Year
1 Year Success Rate
2/8 ratings generated profit
1 Year Average Return
-11.61%
reiterated a buy rating last month
Copying John Hester's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -11.61% per trade.
---